Angiosan 320 mg Filmtabletten

Hauptinformation

  • Handelsname:
  • Angiosan 320 mg Filmtabletten
  • Einheiten im Paket:
  • 7 Stück (PVC/PE/PVDC/Alu-Blister), Laufzeit: 36 Monate,14 Stück (PVC/PE/PVDC/Alu-Blister), Laufzeit: 36 Monate,28 Stück (PVC/PE/
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Angiosan 320 mg Filmtabletten
    Österreich
  • Sprache:
  • Deutsch

Therapeutische Informationen

  • Therapiebereich:
  • Valsartan

Weitere Informationen

Status

  • Quelle:
  • AGES
  • Zulassungsnummer:
  • 1-26882
  • Letzte Änderung:
  • 07-11-2016

11-12-2018

FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications

FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications

FDA update on the ongoing investigation into angiotensin II receptor blocker impurities, recalls and current findings.

FDA - U.S. Food and Drug Administration

4-12-2018

Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to all Lots Within Expiry Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylam

Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to all Lots Within Expiry Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylam

– Mylan N.V. (NASDAQ: MYL) today announced that its U.S. based Mylan Pharmaceuticals business is expanding its consumer-level voluntary nationwide recall to include all lots of Valsartan-containing products within expiry. The 104 additional lots include 26 lots of Amlodipine and Valsartan Tablets, USP (including the 5mg/160mg, 10mg/160mg, 5mg/320mg and 10mg/320mg strengths), 51 lots of Valsartan Tablets, USP (including 40 mg, 80 mg, 160 mg and 320 mg strengths), and 27 lots of Valsartan and Hydrochloroth...

FDA - U.S. Food and Drug Administration

28-11-2018

Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity

Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity

Mylan Pharmaceuticals ULC is voluntarily recalling four lots of Mylan-Valsartan tablets (40 mg, 80 mg, 160 mg and 320 mg strength) after testing found low levels of an impurity, N-nitrosodiethylamine (NDEA).

Health Canada

27-11-2018

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets That Are Within Expiry

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets That Are Within Expiry

Teva Pharmaceuticals has initiated a voluntary recall in the United States, to the patient level, of all lots of Amlodipine / Valsartan combination tablets and Amlodipine / Valsartan / Hydrochlorothiazide combination tablets (see table below) due to an impurity detected above specification limits in an active pharmaceutical ingredient (API) manufactured by Mylan India. The impurity found in Mylan’s valsartan API is known as N-nitroso-diethylamine (NDEA), which has been classified as a probable human carc...

FDA - U.S. Food and Drug Administration

23-11-2018

Dilart and Dilart HCT (valsartan)

Dilart and Dilart HCT (valsartan)

Recall - potential contamination

Therapeutic Goods Administration - Australia

21-11-2018

Mylan Initiates Voluntary Nationwide Recall of 15 Lots of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Fou

Mylan Initiates Voluntary Nationwide Recall of 15 Lots of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Fou

Mylan N.V. (NASDAQ: MYL) today announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall to the consumer level of select lots of Valsartan-containing products, including six lots of Amlodipine and Valsartan Tablets, USP (including the 5mg/160mg, 10mg/160mg, and 10mg/320mg strengths), seven lots of Valsartan Tablets, USP (including 40 mg, 80 mg, 160 mg, and 320 mg strengths), and two lots of Valsartan and Hydrochlorothiazide Tablets, USP 320mg/25mg strength. ...

FDA - U.S. Food and Drug Administration

13-11-2018

Felimazole 2.5 mg ad us. vet., Filmtabletten fuer Katzen

Felimazole 2.5 mg ad us. vet., Filmtabletten fuer Katzen

● Änderung Text "Anwendungseinschränkungen", "Wechselwirkungen" und "Sonstige Hinweise"

Institut für Veterinärpharmakologie und toxikologie

13-11-2018

Felimazole 5 mg ad us. vet., Filmtabletten fuer Katzen

Felimazole 5 mg ad us. vet., Filmtabletten fuer Katzen

● Änderung Text "Anwendungseinschränkungen", "Wechselwirkungen" und "Sonstige Hinweise"

Institut für Veterinärpharmakologie und toxikologie

14-12-2018

OCALIVA® 5 mg / 10 mg Filmtabletten

Rote - Liste

14-12-2018

Nystatin acis® Filmtabletten

Rote - Liste

14-12-2018

Seroxat 20 mg Filmtabletten

Rote - Liste

13-12-2018

Bisoprolol comp. AbZ Filmtabletten

Rote - Liste

13-12-2018

Efavirenz Teva 600 mg Filmtabletten

Rote - Liste

13-12-2018

Valsartan comp.-CT 320 mg/12,5 - 25 mg

Rote - Liste

13-12-2018

Ursofalk® 500mg Filmtabletten

Rote - Liste

13-12-2018

Zolpidem-ratiopharm 5 mg Filmtabletten

Rote - Liste

11-12-2018

Concor 5 mg/10 mg Filmtabletten

Rote - Liste

6-12-2018

Imanivec® 400 mg Filmtabletten

Rote - Liste

6-12-2018

Tioblis® Filmtabletten

Rote - Liste

6-12-2018

Imanivec® 100 mg Filmtabletten

Rote - Liste

5-12-2018

Levetiracetam UCB® Filmtabletten

Rote - Liste

5-12-2018

Forxiga® 5 mg/10 mg Filmtabletten

Rote - Liste

4-12-2018

GINKGOVITAL Heumann® Filmtabletten

Rote - Liste

4-12-2018

Telzir 700 mg Filmtabletten

Rote - Liste

3-12-2018

Alunbrig® Filmtabletten

Rote - Liste

28-11-2018

Deferipron Lipomed 500 mg Filmtabletten

Rote - Liste

28-11-2018

Xadago 50 mg / 100 mg Filmtabletten

Rote - Liste

28-11-2018

Baraclude® 0,5 mg/1 mg Filmtabletten

Rote - Liste

27-11-2018

Olmedipin Filmtabletten

Rote - Liste

23-11-2018

Combivir Filmtabletten

Rote - Liste

22-11-2018

Damara® 75 Mikrogramm Filmtabletten

Rote - Liste

21-11-2018

Epivir 150 / 300 mg Filmtabletten

Rote - Liste

20-11-2018

Qlaira® Filmtabletten

Rote - Liste

20-11-2018

SUSTIVA® 600 mg Filmtabletten

Rote - Liste

16-11-2018

Fycompa® Filmtabletten

Rote - Liste

15-11-2018

Sevredol® 10 mg/20 mg Filmtabletten

Rote - Liste

14-11-2018

Plavix® Filmtabletten

Rote - Liste

14-11-2018

DuoPlavin® 75 mg/100 mg Filmtabletten

Rote - Liste

14-11-2018

Iscover® 75 mg Filmtabletten

Rote - Liste

13-11-2018

Relifex® 500 mg Filmtabletten

Rote - Liste

12-11-2018

Actonel® 30 mg Filmtabletten

Rote - Liste

12-11-2018

Clopidogrel AbZ 75 mg Filmtabletten

Rote - Liste

12-11-2018

Actonel® 5 mg Filmtabletten

Rote - Liste

12-11-2018

Actonel® 75 mg Filmtabletten

Rote - Liste

8-11-2018

Zydelig® Filmtabletten

Rote - Liste

6-11-2018

Symkevi® 100 mg/150 mg Filmtabletten

Rote - Liste

2-11-2018

Tramundin® 50 mg Filmtabletten

Rote - Liste

31-10-2018

Quetiapin-Hormosan Filmtabletten

Rote - Liste

31-10-2018

Viread® 163 mg Filmtabletten

Rote - Liste

31-10-2018

Viread® 123 mg Filmtabletten

Rote - Liste

31-10-2018

Viread® 204 mg Filmtabletten

Rote - Liste

31-10-2018

Viread® 245 mg Filmtabletten

Rote - Liste